SEATTLE, Oct. 24 /CNW/ - Oncothyreon Inc. (Nasdaq: ONTY) (TSX:ONY), a
biotechnology company specializing in the development of innovative
therapeutic products for the treatment of cancer, today announced that Robert
Kirkman, M.D., President and Chief Executive Officer, is scheduled to present
at the 7th Annual BIO Investor Forum in San Francisco on Friday, October 31,
2008 at 8:00 a.m. Pacific Time.
A live and archived webcast of Dr. Kirkman's presentation can be accessed
at www.oncothyreon.com under the "News & Events" section.
Oncothyreon is a biotechnology company specializing in the development of
innovative therapeutic products for the treatment of cancer. Oncothyreon's
goal is to develop and commercialize novel synthetic vaccines and targeted
small molecules that have the potential to improve the lives and outcomes of
cancer patients. For more information, visit www.oncothyreon.com.
For further information:
For further information: Investor and Media Relations Contact: Julie
Rathbun, Rathbun Communications, (206) 769-9219, firstname.lastname@example.org